Pharmacokinetics, distribution, and excretion of 125I-labeled human plasma-derived-FVIIa and -FX with MC710 (FVIIa/FX mixture) in rats

导出原文传递

翻译打印收藏纠错

作者： Nakatomi,Y. ^[1] ; Tsuji,M. ^[2] ; Nakashima,T. ^[3] ; Gokudan,S. ^[4] ; Miyazaki,H. ; Tomokiyo,K. ; Ogata,Y. ; Harano,S. ; Matsui,H. ; Shigaki,T. ; Nakamura,T. ; Mogi,M.

作者单位： Drug Safety Research Laboratories, Shin Nippon Biomedical Laboratories, Kagoshima, Japan ^[1] Pathology Department, Chemo-Sero-Therapeutic Research Institute, KAKETSUKEN, Kumamoto, Japan ^[2] Pharmacokinetics and Bioanalysis Center, Shin Nippon Biomedical Laboratories, Wakayama, Japan ^[3] Therapeutic Protein Product Research Department, Chemo-Sero-Therapeutic Research Institute ^[4]

关键词 Bypassing agents FVIIa FX Hemophilia Inhibitor

发布时间 2013-11-20

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Thrombosis Research

2012年129卷1期

60-67页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Pharmacokinetics, distribution, and excretion of 125I-labeled human plasma-derived-FVIIa and -FX with MC710 (FVIIa/FX mixture) in rats

Thrombosis Research

相似文献

Thrombosis Research

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Pharmacokinetics, distribution, and excretion of 125I-labeled human plasma-derived-FVIIa and -FX with MC710 (FVIIa/FX mixture) in rats

Thrombosis Research

相似文献

Thrombosis Research

相关期刊

检索历史清除